PTC Therapeutics, Inc.
PTCT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Revenue | $16.29M | $7.20M |
| Net Income | -$4.42M | -$7.30M |
| EPS Diluted | -$0.19 | -$1,605.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR